These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6721993)

  • 21. Acedapsone treatment of leprosy patients: response versus drug disposition.
    Peters JH; Murray JF; Gordon GR; Levy L; Russell DA; Scott GC; Vincin DR; Shepard CC
    Am J Trop Med Hyg; 1977 Jan; 26(1):127-36. PubMed ID: 842774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous determination of dapsone, monoacetyldapsone and pyrimethamine in whole blood and plasma by high-performance liquid chromatography.
    Lemnge MM; Rønn A; Flachs H; Bygbjerg IC
    J Chromatogr; 1993 Apr; 613(2):340-6. PubMed ID: 8491823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid high-performance liquid chromatographic method for the determination of dapsone and monoacetyldapsone in biological fluids.
    Zuidema J; Modderman ES; Hilbers HW; Merkus FW; Huikeshoven H
    J Chromatogr; 1980 Apr; 182(1):130-5. PubMed ID: 7380899
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
    Pochopin NL; Charman WN; Stella VJ
    Drug Metab Dispos; 1994; 22(5):770-5. PubMed ID: 7835230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and sensitive liquid chromatographic method for the determination of dapsone and monoacetyldapsone in plasma and urine.
    Horai Y; Ishizaki T
    J Chromatogr; 1985 Dec; 345(2):447-52. PubMed ID: 4086615
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of cancer chemotherapy on dapsone N-acetylation in man.
    Philip PA; Harper PG; Rogers HJ
    Cancer Chemother Pharmacol; 1989; 23(6):395-6. PubMed ID: 2713961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute dapsone intoxication: a case with prolonged symptoms.
    Elonen E; Neuvonen PJ; Halmekoski J; Mattila MJ
    Clin Toxicol; 1979; 14(1):79-85. PubMed ID: 436385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
    Najim RA; Farid YY; Samad TA; Shihab SA
    East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassessment of dapsone as a marker of acetylator phenotypes.
    Wiggan EB; Dennis S; Reele SB; Luke DR
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):262-8. PubMed ID: 1889912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-adipose administration of monoacetyldapsone to healthy volunteers.
    Pieters FA; Zuidema J
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):510-6. PubMed ID: 3819527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
    Hanson A; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylator phenotype in relation to age and gender in the Baltimore Longitudinal Study of Aging.
    Korrapati MR; Sorkin JD; Andres R; Muller DC; Loi CM; Vesell ES; Vestal RE
    J Clin Pharmacol; 1997 Feb; 37(2):83-91. PubMed ID: 9055133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.
    Ahmad RA; Rogers HJ
    Eur J Clin Pharmacol; 1980 Feb; 17(2):129-33. PubMed ID: 7371704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylator phenotype in Iraqi patients with atopic dermatitis.
    Najim RA; Al-Waiz MM; Al-Razzuqi RA
    Dermatol Online J; 2006 Dec; 12(7):1. PubMed ID: 17459287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.
    Edstein MD; Shanks GD; Teja-Isavadharm P; Rieckmann KH; Webster HK
    Br J Clin Pharmacol; 1994 Jan; 37(1):67-70. PubMed ID: 8148220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of antimalarial drugs. II. Simultaneous measurement of dapsone, monoacetyldapsone and pyrimethamine in human plasma.
    Edstein M
    J Chromatogr; 1984 May; 307(2):426-31. PubMed ID: 6736190
    [No Abstract]   [Full Text] [Related]  

  • 39. Dapsone and monoacetyldapsone determined in serum and saliva by a sensitive high-performance liquid chromatographic method with a single extraction step.
    Pieters FA; Vincken BJ; Zuidema J
    J Chromatogr; 1987 Nov; 422():322-7. PubMed ID: 3437021
    [No Abstract]   [Full Text] [Related]  

  • 40. High-performance liquid chromatographic method with ultraviolet detection for the determination of dapsone and its hydroxylated metabolite in human plasma.
    Kwadijk S; Toraño JS
    Biomed Chromatogr; 2002 May; 16(3):203-8. PubMed ID: 11920946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.